Evidence map›Paper›PMID 42214675›Full record

ArticleThe Journal of biological chemistry2026

Cell type-specific expression and subcellular localization of the human insulin upstream open reading frame (INSU) protein in pancreatic β-cells.

Qing-Rong Liu, Min Zhu, Lisa M Hartnell, Jane Tian, Qin Yao, Xiaoming Zhong, Chee W Chia, Paritosh Ghosh, Máire E Doyle, Jennifer F O'Connell and 1 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qing-Rong LiuLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA. Electronic address: qliu@mail.nih.gov.
Min ZhuLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Lisa M HartnellLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Jane TianLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Qin YaoLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Xiaoming ZhongCenter of Excellence for Leukemia Studies, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
Chee W ChiaLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Paritosh GhoshLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Máire E DoyleLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Jennifer F O'ConnellLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA.
Josephine M EganLaboratory of Clinical Investigation, NIA/IRP/NIH, Baltimore, Maryland, USA. Electronic address: eganj@grc.nia.nih.gov.

Funding

The Human Islet Distribution Coordinating Center (UC4)UC4DK098085 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI EVANS-MOLINA, CARMELLA, NILAND, JOYCE CAROL · 2012 to 2017
$25.6M
INTERDISCIPLINARY RESEARCH TRAINING PROGRAM ON AGINGT32AG000214 · NIA · UNIVERSITY OF IOWA · PI WALLACE, ROBERT BRUCE · 1991 to 2000
$164k
NIA NIH HHS T32 AG000214NIDDK NIH HHS UC4 DK098085
6 · The paper itself

Abstract

INSU was evolutionarily selected in human and chimp genomes by deletion of the 16 bp in INS 5'UTR regions present in other primate species that do not contain the upstream open reading frame. We now aim to identify the islet cell type in which INSU is produced, its subcellular distribution, and its response to stress in human islets. To do this, we developed an INSU specific rabbit polyclonal antibody, and we employed immunohistochemistry, immunofluorescence, and immuno-gold labeling with EM technologies. We used LC-MS/MS-based selected reaction monitoring proteomic assay to quantify INSU in islets, plasma and cerebral spinal fluid. Unlike mature insulin, INSU levels were unchanged in plasma and cerebral spinal fluid 2 hours after continuous intravenous glucose infusion. The INSU immunohistochemistry signal partially overlapped with that of insulin and was more intensely polarized than insulin in β-cells in islets. INSU was not present in α-, δ-, ε-, or PP-cells. Dual immunofluorescence and immuno-gold EM showed that INSU was present in immature insulin granules and crinosomes, but there was little to none present in mature secretory granules, implying INSU involvement in quality control of β-cells.

Indexed as

InsulinInsulin-Secreting CellsOpen Reading FramesAnimalsHumansRabbitsInsulincrinophagydiabetesevolutioninsulinisletsproteomics

Identifiers

PMID42214675
PMCPMC13314798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.